Journal
ENDOCRINE-RELATED CANCER
Volume 19, Issue 4, Pages 509-526Publisher
BIOSCIENTIFICA LTD
DOI: 10.1530/ERC-12-0100
Keywords
-
Categories
Funding
- National Health and Medical Research Council of Australia (NHMRC) [511153]
- ANZ Trustees PhD Medical Research scholarship
- National Breast Cancer Foundation (NBCF), Australia
- NHMRC of Australia
- Cancer Institute NSW
- NCBF
- Victorian Government
- National Breast Cancer Foundation [IF-12-05] Funding Source: researchfish
Ask authors/readers for more resources
Protein arginine methyltransferase-6 (PRMT6) regulates steroid-dependent transcription and alternative splicing and is implicated in endocrine system development and function, cell death, cell cycle, gene expression and cancer. Despite its role in these processes, little is known about its function and cellular targets in breast cancer. To identify novel gene targets regulated by PRMT6 in breast cancer cells, we used a combination of small interfering RNA and exon-specific microarray profiling in vitro coupled to in vivo validation in normal breast and primary human breast tumours. This approach, which allows the examination of genome-wide changes in individual exon usage and total transcript levels, demonstrated that PRMT6 knockdown significantly affected i) the transcription of 159 genes and ii) alternate splicing of 449 genes. The PRMT6-dependent transcriptional and alternative splicing targets identified in vitro were validated in human breast tumours. Using the list of genes differentially expressed between normal and PRMT6 knockdown cells, we generated a PRMT6-dependent gene expression signature that provides an indication of PRMT6 dysfunction in breast cancer cells. Interrogation of several well-studied breast cancer microarray expression datasets with the PRMT6 gene expression signature demonstrated that PRMT6 dysfunction is associated with better overall relapse-free and distant metastasis-free survival in the oestrogen receptor (ER (ESR1)) breast cancer subgroup. These results suggest that dysregulation of PRMT6-dependent transcription and alternative splicing may be involved in breast cancer pathophysiology and the molecular consequences identifying a unique and informative biomarker profile. Endocrine-Related Cancer (2012) 19 509-526
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available